SPTBN2 and pancreatic adenocarcinoma: Kaplan–Meier survival curves of PAAD patients showed that high expression of SPTBN2 correlated with poor OS, DSS, and PFI (Fig. 2d, p < 0.05), which was consistent with the previous Cox regression results.